title: Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.
abstract: Type III interferons (IFNs), also called lambda interferons (IFN-λ), comprise three isoforms, IFN-λ1 (interleukin-29 [IL-29]), IFN-λ2 (IL-28A), and IFN-λ3 (IL-28B). Only limited information is available on their expression and biological functions in humans. Type I and type II IFNs protect human pancreatic islets against coxsackievirus infection, and this is important since such viruses have been proposed to play a role in the development of human type 1 diabetes. Here we investigated whether type III IFN is expressed during infection of human islet cells with coxsackievirus and if type III IFN regulates permissiveness to such infections. We show that human islets respond to a coxsackievirus serotype B3 (CVB3) infection by inducing the expression of type III IFNs. We also demonstrate that islet endocrine cells from nondiabetic individuals express the type III IFN receptor subunits IFN-λR1 and IL-10R2. Pancreatic alpha cells express both receptor subunits, while pancreatic beta cells express only IL-10R2. Type III IFN stimulation elicited a biological response in human islets as indicated by the upregulated expression of antiviral genes as well as pattern recognition receptors. We also show that type III IFN significantly reduces CVB3 replication. Our studies reveal that type III IFNs are expressed during CVB3 infection and that the expression of the type III IFN receptor by the human pancreatic islet allows this group of IFNs to regulate the islets' permissiveness to infection. Our novel observations suggest that type III IFNs may regulate viral replication and thereby contribute to reduced tissue damage and promote islet cell survival during coxsackievirus infection.
authors: Department of Medicine HS, The Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
authors: Katharina
authors: K
authors: Lind
authors: Sarah J
authors: SJ
authors: Richardson
authors: Pia
authors: P
authors: Leete
authors: Noel G
authors: NG
authors: Morgan
authors: Olle
authors: O
authors: Korsgren
authors: Malin
authors: M
authors: Flodström-Tullberg
mesh_terms: D000368:Aged; D000704:Analysis of Variance; D003384:Coxsackievirus Infections / Q000276:immunology*; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D007372:Interferons; D007378:Interleukins / Q000276:immunology*; D007515:Islets of Langerhans / Q000378:metabolism* / Q000821:virology; D008297:Male; D008875:Middle Aged; D060888:Real-Time Polymerase Chain Reaction; D017471:Receptors, Interferon / Q000276:immunology*; D014779:Virus Replication / Q000276:immunology*; D000095022:Interferon Lambda
chemical_list: D007372:Interferons; D007378:Interleukins; D017471:Receptors, Interferon; C000624353:interferon-lambda, human; D000095022:Interferon Lambda
references: J Virol. 2012 Apr;86(8):4477-87
references: 22301155
references: PLoS One. 2010 Dec 08;5(12):e15200
references: 21170333
references: Genes Immun. 2009 Dec;10(8):702-14
references: 19798076
references: Diabetologia. 2009 Jun;52(6):1143-51
references: 19266182
references: Cold Spring Harb Perspect Med. 2012 Jul;2(7):a007690
references: 22762021
references: Gastroenterology. 2012 Apr;142(4):978-88
references: 22248663
references: J Virol. 2009 Apr;83(8):3834-42
references: 19193806
references: J Immunol. 2015 Sep 1;195(5):1911-20
references: 26297790
references: Antiviral Res. 2012 Jul;95(1):57-65
references: 22584351
references: Immunity. 2006 Sep;25(3):373-81
references: 16979569
references: Diabetologia. 2012 Dec;55(12):3273-83
references: 22983635
references: Nat Immunol. 2003 Jan;4(1):69-77
references: 12483210
references: Nat Immunol. 2002 Apr;3(4):373-82
references: 11919579
references: Curr Opin Immunol. 2011 Oct;23(5):583-90
references: 21840693
references: PLoS One. 2012;7(2):e32061
references: 22355409
references: Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5115-20
references: 17360338
references: Diabetologia. 2004 Feb;47(2):225-39
references: 14727023
references: J Virol. 2010 Jan;84(1):254-60
references: 19846534
references: Thorax. 2012 Jun;67(6):517-25
references: 22213737
references: Diabetes. 2003 Aug;52(8):2025-34
references: 12882919
references: BMJ. 2011 Feb 03;342:d35
references: 21292721
references: Immunol Cell Biol. 2012 May;90(5):483-91
references: 22410872
references: J Biol Chem. 2009 May 15;284(20):13348-13354
references: 19324880
references: Biochem Biophys Res Commun. 2003 Aug 29;308(3):474-9
references: 12914774
references: Virology. 2011 May 10;413(2):283-92
references: 21435672
references: J Virol. 2006 Jun;80(11):5637-43
references: 16699045
references: Virology. 2007 Oct 10;367(1):92-101
references: 17559902
references: J Gen Virol. 2000 Oct;81(Pt 10):2341-2364
references: 10993923
references: Nat Med. 1998 Jul;4(7):781-5
references: 9662368
references: J Autoimmun. 2001 May;16(3):211-7
references: 11334485
references: Nat Genet. 2006 Jun;38(6):617-9
references: 16699517
references: Transplantation. 2004 Nov 15;78(9):1367-75
references: 15548977
references: PLoS Pathog. 2008 Mar 14;4(3):e1000017
references: 18369468
references: Nat Immunol. 2003 Jan;4(1):63-8
references: 12469119
references: Virology. 2010 May 25;401(1):42-8
references: 20206372
references: Clin Exp Immunol. 2012 Apr;168(1):30-8
references: 22385234
references: J Immunol. 2005 Feb 1;174(3):1171-7
references: 15661870
references: J Leukoc Biol. 2009 Jul;86(1):23-32
references: 19304895
references: Science. 2009 Apr 17;324(5925):387-9
references: 19264985
references: Diabetologia. 2002 May;45(5):693-702
references: 12107750
references: J Interferon Cytokine Res. 2011 Jan;31(1):79-87
references: 21166595